MarkNtel Advisors recently published a detailed industry analysis of the Global Prostate Cancer Treatment Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.

Global Prostate Cancer Treatment Market, Share, and Trends Analysis Report – Industry Overview and Forecast to 2027

The Prostate Cancer Treatment Market is projected to grow at a CAGR of around 10.8% during the forecast period, i.e., 2022-27.

Key Findings in Global Prostate Cancer Treatment Market:

Historical Analysis: 2017–2020

Base Year: 2021

Forecast Period: 2022–2027

Leading Market Players- Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol Myers Squibb, Eisai Co. Ltd., Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Merck & Co., Inc., Novartis International AG, Pfizer Inc., Sanofi S.A., Others

Key Highlights of the Report

Market Dimensions & Projections

Pricing Evaluation,

Recent Strategic Moves by Companies,

Primary Stakeholders,

Analysis of Import and Export Trends,

Competitive Landscape Assessment,

Emerging Opportunities,

Market Trends and Indicators

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

https://www.marknteladvisors.com/query/request-sample/prostate-cancer-market.html

What segments define the Global Prostate Cancer Treatment Market from 2022 to 2027? How do these segments contribute to market dynamics and growth?

By Diagnosis

Tissue Biopsy

Transrectal Ultrasound

Prostate-specific Antigen Testing

Urine Testing

Imaging

According to report, Prostate cancer was diagnosed traditionally by Digital Rectal Examination (DRE) & Prostate-specific Antigen (PSA) testing, followed by the Transrectal Ultrasound (TRUS) guided biopsy.

By Treatment

Surgery

Radical Prostatectomy

Cryotherapy

Orchiectomy (Surgical Castration)

Hormone Therapy

LHRH (Luteinizing Hormone-Releasing Hormone) Agonists

Leuprolide (Lupron, Eligard)

Goserelin (Zoladex)

Triptorelin (Trelstar)

Leuprolide mesylate (Camcevi)

LHRH (Luteinizing Hormone-Releasing Hormone) Antagonists

Degarelix (Firmagon)

Relugolix (Orgovyx)

Radiation Therapy

External Beam Radiation Therapy (EBRT)

Proton Beam Radiation Therapy

Three-Dimensional Conformal Radiation Therapy (3D-CRT)

Stereotactic Body Radiation Therapy (SBRT)

Brachytherapy (Internal Radiation Therapy)

Radiopharmaceuticals

Chemotherapy

Docetaxel (Taxotere)

Cabazitaxel (Jevtana)

Mitoxantrone (Novantrone)

Estramustine (Emcyt)

Targeted Therapy

Rucaparib (Rubraca)

Olaparib (Lynparza)

According to report, Of all treatments, surgery is projected to dominate the Global Prostate Cancer Market with the largest share during 2022-27.

By End-User

Hospitals

Clinics

Explore the Complete Global Prostate Cancer Treatment Market Analysis Report –

https://www.marknteladvisors.com/research-library/prostate-cancer-market.html

Geographical Analysis: Global Prostate Cancer Treatment Market

By Region

North America

South America

Europe

Middle East & Africa

Asia-Pacific

Global Prostate Cancer Treatment Market Recent Development:

In June 2021, Novartis International AG announced receiving approval from the US Food & Drug Administration (FDA) for the Breakthrough Therapy Designation (BTD) to 177Lu-PSMA-617 in patients with conditions of metastatic castration-resistant prostate cancer (mCRPC).

In January 2021, the FDA also approved Relugolix (Orgovyx), a new drug that would modify the therapy for advanced prostate cancer, and showed remarkable success in reducing testosterone levels in men with advanced prostate cancer, as found through a massive clinical trial.

Key Questions Addressed in This Study

What are the primary factors driving the growth of the Prostate Cancer Treatment Market?

How is the Prostate Cancer Treatment Market expected to evolve over the next five years?

What key insights can be drawn from current trends shaping the market?

What is the current market size, and how is it forecasted to change in the coming years?

What is the future outlook for the market in terms of technological innovation and geographic expansion?

For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/prostate-cancer-market.html

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries informed way and entail parameters like Go-to-Market (GTM), product development, feAmongst both, Off-trade channels are projected to dominate the Global Prostate Cancer Treatment Market with the largest share through 2027.asibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

More Research Studies Report:

https://www.marknteladvisors.com/research-library/india-pan-masala-market.html

https://www.marknteladvisors.com/research-library/india-pan-masala-market.html

https://finance.yahoo.com/news/global-clinical-workflow-management-software-08470047.64.html

https://finance.yahoo.com/news/global-nutraceutical-products-market-estimated-083900585.html

https://finance.yahoo.com/news/global-hemp-fiber-market-surpass-124700442.html

https://finance.yahoo.com/news/global-tire-market-value-reach-140100987.64.html

https://finance.yahoo.com/news/molybdenum-mo-market-reach-7.64-1401007.6492.html

For Media Inquiries, Please Contact:

Email: sales@marknteladvisors.com

Trending Blogs : www.marknteladvisors.com/blogs

Export-import Data : https://www.marknteladvisors.com/export-import-data